Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BetterLife Pharma Inc C.BETR

Alternate Symbol(s):  BETRF

Healthcare
BetterLife Pharma Inc. is a biotechnology company. The Company is primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001, which is in preclinical and is a non-hallucinogenic and non- controlled lysergic acid diethylamide (LSD) derivative in development and that is unregulated and therefore can be... see more

CSE:BETR - Post Discussion

BetterLife Pharma Inc > gaining traction
View:
Post by mrBlockchain on Dec 11, 2020 11:40am

gaining traction

BetterLife is moving up as news filters out about its psychedelic acquistion.

BOL-148 is a game changer
Comment by ndiamond on Dec 12, 2020 2:32am
Significantly undervalued.    I expect we'll almost certainly see $3.00 again.   And higher from there...
Comment by elgin1 on Dec 13, 2020 2:23pm
Totally agree. Bol 148 is a game changer . Unlike all the other psychodelics, Bol 148 is highly potent  and apparently does not have the side effects. We have an experienced pharma team that has the ability to do clinical trials . Time will tell.  
Comment by goldmike on Dec 14, 2020 12:08pm
Buying BETR much better risk / reward market cap is $40M vs MMED $2B
Comment by goldmike on Dec 15, 2020 4:20am
Huge competitive advantage  BetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application
BetterLife Pharma Inc